Gene Therapy Market By Type (Gene Editing, Gene Replacement Therapy, Gene Silencing Therapy, Gene Immunotherapy, Gene Augmentation Therapy, Others), By Vector Type (Viral Vectors {Adeno-Associated Virus (AAV) Vectors, Lentiviral Vectors, Adenoviral Vectors, Herpes Simplex Virus (HSV) Vectors, Others}, Non-Viral Vectors {Lipid Nanoparticles, Polymers, Others}), By Therapeutic Area (Cardiovascular Disorders, Dermatological Disorders, Genetic Disorders, Hematological Disorders, Metabolic Disorders, Oncological Disorders, Ophthalmic Disorders, Other Disorders), By Delivery Method (In-Vivo, Ex-Vivo), By Route of Administration (Intravenous, Topical, Inhalation, Others), and By End-User (Hospitals, Research Institutions, Pharmaceutical and Biotechnology Companies), Global Market Size, Segmental analysis, Regional Overview, Company Share Analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Nov 2024 | Report ID: MI1244 | 215 Pages


Report Coverage:

By Type

  • Gene Editing
  • Gene Replacement Therapy
  • Gene Silencing Therapy
  • Gene Immunotherapy
  • Gene Augmentation Therapy
  • Others

By Vector Type

  • Viral Vectors
    • Adeno-Associated Virus (AAV) Vectors
    • Lentiviral Vectors
    • Adenoviral Vectors
    • Herpes Simplex Virus (HSV) Vectors
    • Others
  • Non-Viral Vectors
    • Lipid Nanoparticles
    • Polymers
    • Others

By Therapeutic Area

  • Cardiovascular Disorders
  • Dermatological Disorders
  • Genetic Disorders
  • Hematological Disorders
  • Metabolic Disorders
  • Oncological Disorders
  • Ophthalmic Disorders
  • Other Disorders

By Delivery Method

  • In-Vivo
  • Ex-Vivo

By Route of Administration

  • Intravenous
  • Topical
  • Inhalation
  • Others

By End-User

  • Hospitals
  • Research Institutions
  • Pharmaceutical and Biotechnology Companies

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Spark Therapeutics
  • Novartis
  • Bluebird Bio
  • Gilead Sciences
  • Biogen
  • Editas Medicine
  • Intellia Therapeutics
  • CRISPR Therapeutics
  • Amgen
  • Regeneron Pharmaceuticals
  • UniQure
  • Sarepta Therapeutics
  • Voyager Therapeutics
  • Orchard Therapeutics
  • Pfizer

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.